Comments
Loading...

Actuate Therapeutics

ACTUNASDAQ
Logo brought to you by Benzinga Data
$8.04
-0.71-8.11%
At close: -
$8.70
0.668.21%
After Hours: Feb 7, 7:57 AM EDT

Actuate Therapeutics (NASDAQ:ACTU) Stock Quotes, Forecast and News Summary

Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.

Open$8.47
Close$8.04
Volume / Avg.26.64K / 52.76K
Day Range$7.82 - $8.60
52 Wk Range5.51 - 11.73
Market Cap$157.03M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest-
Days to Cover2.08

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open$8.47
Close$8.04
Volume / Avg.26.64K / 52.76K
Day Range$7.82 - $8.60
52 Wk Range5.51 - 11.73
Market Cap$157.03M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest-
Days to Cover2.08
About Actuate Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapi...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ACTU
MOLN

FAQ

Q

How do I buy Actuate Therapeutics (ACTU) stock?

A

You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Actuate Therapeutics (ACTU) competitors?

Q

What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?

A

There is no analysis for Actuate Therapeutics to provide a consensus price target.

Q

What is the current price for Actuate Therapeutics (ACTU)?

A

The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $8.04 last updated February 11, 2025 at 4:00 PM EST.

Q

Does Actuate Therapeutics (ACTU) pay a dividend?

A

There are no upcoming dividends for Actuate Therapeutics.

Q

When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?

A

Actuate Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.

Q

Is Actuate Therapeutics (ACTU) going to split?

A

There is no upcoming split for Actuate Therapeutics.

Q

What sector and industry does Actuate Therapeutics (ACTU) operate in?

A

Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch